Finvest
ACI Food Retail · Grocery · Pharmacy · Value · Thesis updated June 14, 2026

Albertsons must save its way through pharmacy pressure

01 Running thesis

A cheap stock with a hard savings test

Albertsons is growing in the right places, but those places do not all carry strong margins. Pharmacy and digital sales bring in traffic and loyalty, yet they also add delivery costs and mix the company toward lower gross profit per dollar of sales.

The new fiscal 2026 guide made the story more complicated. Management expects the Medicare drug price rules in the Inflation Reduction Act to lower reported identical sales, meaning sales at stores open at least a year, by about 150 basis points. They say the profit hit should be near neutral, but the reported sales number will look worse.

The bull case is simple to state and hard to do. If Albertsons executes its $2 billion, 3-year productivity plan, it can offset pharmacy and digital margin pressure, invest in prices, and still grow adjusted EBITDA modestly in fiscal 2026. Buybacks add another support, with about $600 million planned for fiscal 2026 under a refreshed $2 billion authorization.

The bear case is that the savings plan is too ambitious. If grocery volumes weaken, price cuts deepen, or productivity savings arrive late, the company could miss its EBITDA guide. That would make the low valuation look more like a warning than an opportunity.

Apr 2026The fiscal 2025 10-K confirmed 2.0% identical sales growth, 21% digital sales growth, and 51.2 million loyalty members. It also added clearer risks around AI shopping agents and Medicare drug price rules.
Apr 2026Fiscal 2026 guidance added a 150 basis point IRA headwind to identical sales, but management still guided to modest adjusted EBITDA growth. The new $2 billion productivity plan and $2 billion buyback authorization are now central to the thesis.
Jan 2026Q3 showed gross margin excluding fuel and LIFO down 55 basis points year over year. The pressure improved from Q2, but management also flagged the coming IRA sales headwind.
Oct 2025Q2 margin pressure eased to a 63 basis point decline excluding fuel and LIFO, and Albertsons announced a $750 million accelerated share repurchase. That strengthened the capital return side of the bull case.
Jul 2025Q1 filings showed digital sales up 25% and loyalty members up 14%, but gross margin excluding fuel and LIFO fell 85 basis points. Growth was coming with a clear profit tradeoff.
Jul 2025Q1 earnings showed identical sales up 2.8%, led by pharmacy and digital, while adjusted EBITDA fell year over year. The thesis shifted toward whether productivity could catch up to mix pressure.
02 Business model

Stores, scripts, loyalty, and repeat trips

Albertsons makes money by selling food, household goods, health and beauty items, fuel, and prescriptions through its store base and digital channels. The company operates 2,270 retail stores, 1,728 pharmacies, 405 fuel centers, 22 distribution centers, and 19 manufacturing facilities.

The company uses many local banners, but it reports as one business. Management runs 12 geographic divisions that share similar customers, products, and store economics.

Loyalty is a major part of the model. Albertsons had 51.2 million loyalty members in fiscal 2025. Management says digitally engaged customers spend about 2 to 3 times more than customers who are not digitally engaged, and pharmacy users can spend even more.

The weak point is margin. Digital orders add handling and delivery costs. Pharmacy is growing fast, but it carries lower gross margin. Albertsons needs savings from labor, supply chain, sourcing, and technology to keep profit stable.

03 Product portfolio

Where the basket comes from

Cash cow

Non-perishables

This is the largest sales pool at 48.8% of fiscal 2025 revenue. It includes center-store grocery and household staples that drive frequent trips.

Steady

Fresh

Fresh food made up 31.3% of fiscal 2025 revenue. It helps stores win routine grocery trips and can support loyalty when quality is strong.

Growth engine

Pharmacy

Pharmacy was 13.7% of fiscal 2025 revenue and has been a major growth driver. It also lowers gross margin mix, so growth here is not pure profit growth.

Growth engine

Digital

Digital sales grew 21% in fiscal 2025. The channel increases customer engagement, but delivery and handling costs pressure margin.

Steady

Fuel

Fuel was 4.6% of fiscal 2025 revenue. It supports convenience and loyalty trips, though fuel margins and prices can move sharply.

Option

Other

Other revenue was 1.6% of fiscal 2025 revenue. It is small, but it adds extra ways to monetize store traffic and customer data.

04 Business segments

One segment, mixed baskets

Non-perishables49%modest
Fresh31%flat
Pharmacy14%growing fast
Fuel5%flat
Other2%flat

Albertsons reports one operating segment, so this mix uses fiscal 2025 product revenue categories. The company is still highly exposed to U.S. grocery and pharmacy demand.

05 Risk factors

What could break the thesis

Productivity plan falls short

High impact · Medium odds

The $2 billion, 3-year productivity plan is now central to the story. Albertsons needs those savings to offset mix pressure, wage costs, and price investments. If savings lag, adjusted EBITDA guidance could be at risk.

We watchQuarterly updates on productivity savings, SG&A expense, and adjusted EBITDA versus the $3.85 billion to $3.925 billion fiscal 2026 guide.

IRA makes sales look worse

Medium impact · High odds

The Inflation Reduction Act Medicare drug price program is expected to cut fiscal 2026 identical sales by about 150 basis points. Management says the profit impact should be near neutral, but investors may focus on the weaker reported sales line. The risk grows if the program expands or affects more drugs over time.

We watchReported identical sales compared with the 1.5% to 2.5% guide excluding the IRA headwind.

Pharmacy and digital dilute margins

High impact · High odds

Pharmacy and digital are growing, but both pressure gross margin. In Q3 fiscal 2025, gross margin excluding fuel and LIFO fell 55 basis points year over year. If this pressure stays high, Albertsons may need deeper cost cuts just to hold profit steady.

We watchGross margin excluding fuel and LIFO, especially whether management reaches its flat to slightly better fiscal 2026 goal.

Value shoppers force more price cuts

Medium impact · Medium odds

Grocery is very competitive, and shoppers remain focused on price. Albertsons may need to invest more in prices to defend traffic and unit volumes. That would make the savings plan do even more work.

We watchIdentical sales excluding pharmacy, grocery unit volumes, and management comments on price investments.

Legal and deal cleanup lingers

Medium impact · Medium odds

Albertsons still has an ongoing dispute with Kroger over the $600 million merger termination fee. Opioid litigation risk has been reduced by a proposed $774 million settlement framework, but legal costs and timing can still matter. These issues can distract management and use cash.

We watchCourt filings and company updates on the Kroger fee dispute and opioid settlement timing.

AI shopping tools weaken loyalty

Medium impact · Medium odds

Albertsons warned that AI-powered shopping agents could compare and buy products for customers. If those tools focus on price or speed, they could weaken the direct customer relationship. That would make loyalty data less valuable and could raise margin pressure.

We watchChanges in loyalty member growth, digital engagement, and management comments on AI shopping behavior.
06 Quick answers

In one breath

Is Albertsons mainly a grocery company or a pharmacy company?

Albertsons is mainly a grocery retailer. In fiscal 2025, non-perishables and fresh food together made up 80.1% of revenue, while pharmacy made up 13.7%.

Why does pharmacy growth hurt Albertsons margins?

Pharmacy can bring more trips and customer loyalty, but it carries lower gross margin than many grocery categories. That means sales can rise while profit per sales dollar falls.

What is the biggest thing to watch in fiscal 2026?

Watch whether Albertsons can grow adjusted EBITDA while reported identical sales are hurt by the IRA drug price headwind. The key proof points are gross margin, productivity savings, and buyback execution.

Does Albertsons return cash to shareholders?

Yes. Management guided to about $600 million of share repurchases in fiscal 2026 and refreshed the total share repurchase authorization to $2 billion.